PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 127 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,580,000 | +94.6% | 3,060,923 | +93.2% | 2.09% | +40.9% |
| Q3 2019 | $8,007,000 | +114.7% | 1,583,925 | +216.8% | 1.48% | +154.7% |
| Q1 2018 | $3,730,000 | -45.1% | 500,000 | -50.0% | 0.58% | -29.6% |
| Q2 2017 | $6,790,000 | -68.0% | 1,000,000 | -55.5% | 0.82% | -67.9% |
| Q1 2017 | $21,226,000 | -72.6% | 2,248,531 | -74.9% | 2.57% | -70.1% |
| Q4 2016 | $77,338,000 | +36.5% | 8,951,169 | 0.0% | 8.59% | +69.1% |
| Q3 2016 | $56,661,000 | +50.0% | 8,951,169 | 0.0% | 5.08% | +38.3% |
| Q2 2016 | $37,774,000 | -3.2% | 8,951,169 | 0.0% | 3.67% | -2.5% |
| Q1 2016 | $39,027,000 | -28.9% | 8,951,169 | 0.0% | 3.77% | +11.7% |
| Q4 2015 | $54,871,000 | +7.2% | 8,951,169 | 0.0% | 3.38% | +18.5% |
| Q3 2015 | $51,201,000 | -28.1% | 8,951,169 | -6.3% | 2.85% | -25.6% |
| Q2 2015 | $71,252,000 | +21.0% | 9,551,169 | -3.0% | 3.83% | -16.6% |
| Q1 2015 | $58,910,000 | -57.4% | 9,851,169 | -46.2% | 4.59% | -23.7% |
| Q4 2014 | $138,366,000 | +197.8% | 18,302,338 | +104.5% | 6.02% | +23.5% |
| Q3 2014 | $46,457,000 | -18.8% | 8,951,169 | -32.6% | 4.87% | +73.0% |
| Q2 2014 | $57,204,000 | +150.4% | 13,272,338 | +137.6% | 2.82% | +27.2% |
| Q1 2014 | $22,847,000 | +7.2% | 5,586,169 | +39.7% | 2.21% | -21.3% |
| Q4 2013 | $21,320,000 | +22.1% | 4,000,000 | +15.0% | 2.81% | -9.3% |
| Q3 2013 | $17,466,000 | +11.9% | 3,479,348 | -0.6% | 3.10% | +1.5% |
| Q2 2013 | $15,613,000 | – | 3,500,615 | – | 3.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|